KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aehr Test Systems (AEHR) Research & Development (2016 - 2026)

Aehr Test Systems' Research & Development history spans 16 years, with the latest figure at $3.2 million for Q1 2026.

  • For Q1 2026, Research & Development rose 0.86% year-over-year to $3.2 million; the TTM value through Feb 2026 reached $11.7 million, up 17.59%, while the annual FY2025 figure was $10.5 million, 20.0% up from the prior year.
  • Research & Development reached $3.2 million in Q1 2026 per AEHR's latest filing, up from $3.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $3.2 million in Q1 2026 to a low of $1.5 million in Q3 2022.
  • Average Research & Development over 5 years is $2.3 million, with a median of $2.3 million recorded in 2023.
  • Peak YoY movement for Research & Development: skyrocketed 69.32% in 2022, then dropped 4.53% in 2024.
  • A 5-year view of Research & Development shows it stood at $1.6 million in 2022, then grew by 27.14% to $2.0 million in 2023, then grew by 15.42% to $2.3 million in 2024, then soared by 30.58% to $3.0 million in 2025, then rose by 6.56% to $3.2 million in 2026.
  • Per Business Quant, the three most recent readings for AEHR's Research & Development are $3.2 million (Q1 2026), $3.0 million (Q4 2025), and $2.8 million (Q3 2025).